Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Deletion of the TMEM30A gene enables leukemic cell evasion of NK cell cytotoxicity.
Kristenson L, Badami C, Ljungberg A, Islamagic E, Tian Y, Xie G, Hussein BA, Pesce S, Tang KW, Thorén FB. Kristenson L, et al. Among authors: pesce s. Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2316447121. doi: 10.1073/pnas.2316447121. Epub 2024 Apr 1. Proc Natl Acad Sci U S A. 2024. PMID: 38557174 Free PMC article.
Female Malignancies and Immunotherapy: What's New?
Pesce S, Vellone VG, Marcenaro E. Pesce S, et al. Cancers (Basel). 2020 Oct 10;12(10):2909. doi: 10.3390/cancers12102909. Cancers (Basel). 2020. PMID: 33050485 Free PMC article.
Bridging innate NK cell functions with adaptive immunity.
Marcenaro E, Carlomagno S, Pesce S, Moretta A, Sivori S. Marcenaro E, et al. Among authors: pesce s. Adv Exp Med Biol. 2011;780:45-55. doi: 10.1007/978-1-4419-5632-3_5. Adv Exp Med Biol. 2011. PMID: 21842364 Review.
Harnessing Immune Response in Acute Myeloid Leukemia.
Riva C, Vernarecci C, Minetto P, Goda R, Greppi M, Pesce S, Chies M, Zecchetti G, Ferro B, Maio E, Cea M, Lemoli RM, Marcenaro E, Guolo F. Riva C, et al. Among authors: pesce s. J Clin Med. 2023 Sep 7;12(18):5824. doi: 10.3390/jcm12185824. J Clin Med. 2023. PMID: 37762763 Free PMC article. Review.
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells.
Guolo F, Minetto P, Pesce S, Ballerini F, Clavio M, Cea M, Frello M, Garibotto M, Greppi M, Bozzo M, Miglino M, Passannante M, Marcolin R, Tedone E, Colombo N, Mangerini R, Bo A, Ruzzenenti MR, Carlier P, Serio A, Luchetti S, Dominietto A, Varaldo R, Candiani S, Agostini V, Ravetti JL, Del Zotto G, Marcenaro E, Lemoli RM. Guolo F, et al. Among authors: pesce s. Front Immunol. 2021 Nov 5;12:753890. doi: 10.3389/fimmu.2021.753890. eCollection 2021. Front Immunol. 2021. PMID: 34804039 Free PMC article. Clinical Trial.
162 results